Omeros News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.10.24	Omeros' Zaltenibart Gets Rare Pediatric Disease Designation From FDA For C3 Glomerulopathy (RTTNews)
01.04.24	Omeros Corp. Q4 Earnings Summary (RTTNews)
19.10.23	Omeros Appoints Andreas Grauer As Chief Medical Officer (RTTNews)
16.10.23	Omeros To Discontinue ARTEMIS-IGAN Trial - Quick Facts (RTTNews)
29.11.22	Pre-market Movers: SNES, KALA, LEV, EBS, GHG… (RTTNews)
08.11.22	Omeros Receives FDA Decision On Narsoplimab (RTTNews)
15.09.22	Omeros: Narsoplimab Reduces Mortality Risk In Critically Ill COVID-19 Patients (RTTNews)
17.08.22	Omeros Receives FDA's Interim Response On Formal Dispute Resolution Request For Narsoplimab (RTTNews)
29.07.22	Omeros Says FDA Grants Orphan Drug Designation To MASP-3 Inhibitor OMS906 (RTTNews)
23.06.22	Pre-market Movers: BOXD, NN, ARR, SPRC, TOP… (RTTNews)
20.01.22	Omeros Confirms Submission Of Response To FDA On BLA For Narsoplimab In Treatment Of HSCT-TMA (RTTNews)
20.12.21	OMER EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Omeros Corporation Investors with Losses to Inquire About Class Action Investigation - OMER (PR Newswire)
02.12.21	Omeros Adds 5% As Its Omidria Is Being Sold To Rayner Surgical For More Than $1 Bln (RTTNews)
02.12.21	Omeros To Acquire To Sell OMIDRIA Franchise To Rayner Surgical In Over $1 Bln Deal - Quick Facts (RTTNews)
18.10.21	Omeros Gets CRL From FDA For Narsoplimab BLA In Treatment Of HSCT-TMA (RTTNews)
08.10.21	OMER EQUITY ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Omeros Corporation Investors with Losses to Inquire About Class Action Investigation - OMER (PR Newswire)
01.10.21	Omeros: FDA Finds Deficiencies In BLA For Narsoplimab; Resolution Unlikely Before PDUFA Action Date (RTTNews)
30.09.21	Biotech Stocks Facing FDA Decision In October 2021 (RTTNews)
09.06.21	Omeros : OMS906 Phase 1 Trial Results Show PK/PD Consistent With Low-dose, Once-monthly SC Dosing (RTTNews)
28.05.21	Omeros' Narsoplimab Shows Promising Data In Covid-19 Patients Treated Through Compassionate Use (RTTNews)
28.05.21	Omeros Reports Preliminary Results From Critically Ill COVID-19 Patients Treated With Narsoplimab (RTTNews)
20.05.21	Omeros Slumps As FDA Extends Decision Date For Narsoplimab (RTTNews)
23.03.21	Omeros Says First Patients Dosed With Narsoplimab In I-SPY COVID-19 Trial (RTTNews)
03.12.20	Stock Alert: Omeros Corporation Gains 13% (RTTNews)
03.12.20	Pre-market Movers In Healthcare Sector: OMER, ITRM, CLSD, CDMO, ACOR… (RTTNews)
11.08.20	CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs (RTTNews)
10.08.20	Stock Alert: Omeros Jumps To New 52-week High On Positive Narsoplimab Data (RTTNews)
10.08.20	Omeros Says All Narsoplimab-treated Patients Recovered From COVID-19 (RTTNews)
03.03.20	Stock Alert: Omeros Corp. (OMER) Catches Eye (RTTNews)
29.10.19	AZN's POSEIDON Has Poise, MRTX On The Move, MOR Drops Atopic Dermatitis Trial (RTTNews)
02.10.18	AKRX Slumps On Court Ruling, OMER Reports IgA Data, INSM On Watch (RTTNews)
29.09.18	Week Ahead In Pharmaceuticals: 5 Stocks To Watch (OMER, BOLD, XLRN...) (RTTNews)
02.09.18	10 Pharma Stocks To Watch This Month (RTTNews)
26.07.18	Omeros Announces Voluntary Dismissal Of Infringement Suit Against Sandoz (RTTNews)
15.05.18	ALL Eyes On PRPH, TNDM Soars On Analyst Upgrade, OMER Back In Focus (RTTNews)
27.03.18	DXR Continues To Slide, Keep An Eye On ASNS, Data Fails To Propel PTGX (RTTNews)
23.03.18	OMER Back In Focus, INNT Moving Ahead, Keep An Eye On EARS (RTTNews)
23.02.18	ADXS Falls On Stock Offering, OMER Down 36% In 5 Days, Analyst Downgrades ALKS (RTTNews)
18.01.18	Lincoln Financial Group Solves Cloud to Local IT Integration with Relational Junction (PR Newswire)
13.12.17	ADRO Dumps CRS-207, Another Win For CoolSculpting, FDA Expands GSK's Nucala Use (RTTNews)
10.11.17	Omeros Remains Firmly Positive After Early Rally (RTTNews)
10.11.17	FDA Approves DVAX's Hep B Vaccine, OMER Catches Eyes, It's 4 For SGEN's Adcetris (RTTNews)
03.11.17	DRNA Soars On NASH Deal, JUNO Transcends Expectations, FMI On Solid Footing (RTTNews)
26.10.17	Omeros Reports Additional and Consistently Positive Data for OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (PR Newswire)
25.10.17	ATOS Catches Eyes, PTIE Gains, CNCE Hits Right Notes, SMMT Keeps Sliding (RTTNews)
18.08.17	Biotech Stocks on Investors' Radar -- Ocular Therapeutix, Omeros, OvaScience, and Regulus Therapeutics (PR Newswire)
16.08.17	Gainers & Losers Of Aug.15: DOVA, OTIC, GTHX, OMER, ALT... (RTTNews)
15.08.17	FDA Lifts Hold On CVM's Study, FATE On Track, REGN, OPHT, ZYNE All Flunk Trials (RTTNews)
10.08.17	Gainers & Losers Of Aug.9: NTRA, ACHN, OMER, SGRY, PGNX... (RTTNews)
07.08.17	AQB Reaps A Bounty, CLSN Ends Dual Listing, MNK Opens Wallet, OMER On Watch (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Omeros Corp

Aktien Top/Flop

Meistgelesene Nachrichten